Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maud-Emmanuelle Gilles

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Expert Opinion on Therapeutic Targets|October 18, 2018
Let-7 microRNA as a potential therapeutic target with implications for immunotherapyMaud-Emmanuelle Gilles, Frank J Slack
Oncotarget|September 17, 2019
Tumor penetrating nanomedicine targeting both an oncomiR and an oncogene in pancreatic cancerMaud-Emmanuelle Gilles, Liangliang Hao, Kaelyn Brown, et al.
Molecular Therapy. Nucleic Acids|December 20, 2019
Hydrophobically Modified let-7b miRNA Enhances Biodistribution to NSCLC and Downregulates HMGA2 In VivoMeirav Segal, Annabelle Biscans, Maud-Emmanuelle Gilles, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 7, 2020
Antagonist of nucleolin, N6L, inhibits neovascularization in mouse models of retinopathiesMarie Darche, Mélissande Cossutta, Laure Caruana, et al.
Nature Structural & Molecular Biology|January 22, 2019
Xist RNA antagonizes the SWI/SNF chromatin remodeler BRG1 on the inactive X chromosomeTeddy Jégu, Roy Blum, Jesse C Cochrane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2018
Personalized RNA Medicine for Pancreatic CancerMaud-Emmanuelle Gilles, Liangliang Hao, Ling Huang, et al.
Oncotarget|November 23, 2017
Multivalent cationic pseudopeptide polyplexes as a tool for cancer therapyZoi Diamantopoulou, Maud-Emmanuelle Gilles, Maha Sader, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 19, 2019
Weibel-Palade Bodies Orchestrate Pericytes During AngiogenesisMélissande Cossutta, Marie Darche, Gilles Carpentier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2020
Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth <i>In Vitro</i> and <i>In Vivo</i>Eleni Anastasiadou, Anita G Seto, Xuan Beatty, et al.
Cancer Research|October 19, 2016
Nucleolin Targeting Impairs the Progression of Pancreatic Cancer and Promotes the Normalization of Tumor VasculatureMaud-Emmanuelle Gilles, Federica Maione, Mélissande Cossutta, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Expert Opinion on Therapeutic Targets|October 18, 2018
Let-7 microRNA as a potential therapeutic target with implications for immunotherapyMaud-Emmanuelle Gilles, Frank J Slack
Oncotarget|September 17, 2019
Tumor penetrating nanomedicine targeting both an oncomiR and an oncogene in pancreatic cancerMaud-Emmanuelle Gilles, Liangliang Hao, Kaelyn Brown, et al.
Molecular Therapy. Nucleic Acids|December 20, 2019
Hydrophobically Modified let-7b miRNA Enhances Biodistribution to NSCLC and Downregulates HMGA2 In VivoMeirav Segal, Annabelle Biscans, Maud-Emmanuelle Gilles, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 7, 2020
Antagonist of nucleolin, N6L, inhibits neovascularization in mouse models of retinopathiesMarie Darche, Mélissande Cossutta, Laure Caruana, et al.
Nature Structural & Molecular Biology|January 22, 2019
Xist RNA antagonizes the SWI/SNF chromatin remodeler BRG1 on the inactive X chromosomeTeddy Jégu, Roy Blum, Jesse C Cochrane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2018
Personalized RNA Medicine for Pancreatic CancerMaud-Emmanuelle Gilles, Liangliang Hao, Ling Huang, et al.
Oncotarget|November 23, 2017
Multivalent cationic pseudopeptide polyplexes as a tool for cancer therapyZoi Diamantopoulou, Maud-Emmanuelle Gilles, Maha Sader, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 19, 2019
Weibel-Palade Bodies Orchestrate Pericytes During AngiogenesisMélissande Cossutta, Marie Darche, Gilles Carpentier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2020
Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth <i>In Vitro</i> and <i>In Vivo</i>Eleni Anastasiadou, Anita G Seto, Xuan Beatty, et al.
Cancer Research|October 19, 2016
Nucleolin Targeting Impairs the Progression of Pancreatic Cancer and Promotes the Normalization of Tumor VasculatureMaud-Emmanuelle Gilles, Federica Maione, Mélissande Cossutta, et al.
Pageof 1